The New York Stock Exchange, BBVA, Docomo Capital and USAA-backed crypto trading platform operator is changing tack from an IPO to a direct listing.

Invenergy, National Grid, Salesforce, Wells Fargo and Deutsche Telekom participated in the asset-tracking software developer’s latest round, which brought its total funding to $92m.

The firm announced its second fund the same day as one of its portfolio companies, University of Wyoming-backed Momentus, successfully listed on Nasdaq.

Harvard-linked Sana Biotechnology will raise as much as $397m if it floats at the upper end and underwriters take up the greenshoe option.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Raine Ventures led the Modern Times Group-backed mobile app creation platform's series C round, bringing its total funding to $54m.

SR One reinvested in a series B round for the degenerative disorder drug developer that was led by venture fund Logos Capital.

Georgia Tech-linked battery technology producer Sila Nanotechnologies has more than tripled its valuation to $3.3bn in the series F round.

GV and Novartis Venture Fund joined 6 Dimensions Capital in a round that brought Harvard’s oncology drug developer's overall funding to $160m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.